Results 81 to 90 of about 97,768,553 (153)

Iron Complexes With Proteins, Carbohydrates, and Maillard Products in Dairy Systems: Implication for Fortification, Bioavailability, and Product Functionality

open access: yesComprehensive Reviews in Food Science and Food Safety, Volume 25, Issue 4, July 2026.
ABSTRACT The global prevalence of iron (Fe) deficiency anemia (IDA) continues to pose major public health challenges, necessitating the development of effective fortification strategies. Dairy‐based systems are promising vehicles for Fe fortification and delivery due to their widespread consumption and nutritional value, although their complex matrix ...
Ishara De Silva   +5 more
wiley   +1 more source

Update of the list of qualified presumption of safety (QPS) recommended microbiological agents intentionally added to food or feed as notified to EFSA 24: Suitability of taxonomic units notified to EFSA until March 2026

open access: yesEFSA Journal, Volume 24, Issue 7, July 2026.
Abstract The Qualified Presumption of Safety (QPS) process was developed to provide a harmonised safety assessment approach to support EFSA Scientific Panels and Units. The QPS approach assesses the taxonomic identity, body of knowledge and safety of microorganisms intentionally added to the food and feed chain.
EFSA Panel on Biological Hazards (BIOHAZ)   +26 more
wiley   +1 more source

Safety of lacto‐N‐triose II as a novel food pursuant to Regulation (EU) 2015/2283

open access: yesEFSA Journal, Volume 24, Issue 7, July 2026.
Abstract Following a request from the European Commission, the EFSA Panel on Nutrition, Novel Foods and Food Allergens (NDA) was asked to deliver an opinion on lacto‐N‐triose II (LNTri II) as a novel food (NF) pursuant to Regulation (EU) 2015/2283.
EFSA Panel on Nutrition   +25 more
wiley   +1 more source

Gastrointestinal Journey of Human Milk Oligosaccharides: From Breastfeeding Origins to Functional Roles in Adults

open access: yesMicroorganisms
Human milk oligosaccharides (HMOs) are the third most abundant solid component in human milk and play crucial roles in shaping the gut microbiome and promoting infant health. Although their functions during infancy are well established, emerging evidence
Yosuke Komatsu   +2 more
doaj   +1 more source

The Role of Two Human Milk Oligosaccharides, 2′-Fucosyllactose and Lacto-N-Neotetraose, in Infant Nutrition [PDF]

open access: yes, 2019
Human breast milk contains numerous biomolecules. Human milk oligosaccharides (HMOs) are the third most abundant component of breast milk, after lactose and lipids.
Yulianti Wibowo, -   +14 more
core   +1 more source

A human milk oligosaccharide prevents intestinal inflammation in adulthood via modulating gut microbial metabolism

open access: yesmBio
Observational evidence suggests that human milk oligosaccharides (HMOs) promote the growth of commensal bacteria in early life and adulthood. However, the mechanisms by which HMOs benefit health through modulation of gut microbial homeostasis remain ...
Kasey M. Schalich   +11 more
doaj   +1 more source

2′-Fucosyllactose helps butyrate producers outgrow competitors in infant gut microbiota simulations [PDF]

open access: yes
Summary: A reduced capacity for butyrate production by the early infant gut microbiota is associated with negative health effects, such as inflammation and the development of allergies.
Schoemaker, Ruud   +4 more
core   +3 more sources

Human milk Oligosaccharide 2 '-Fucosyllactose reduces neurodegeneration in stroke brain

open access: yes, 2020
[[abstract]]2 '-Fucosyllactose (2'-FL) is a major oligosaccharide in human milk and is present at trace levels in cow milk. 2'-FL reduces inflammation in the gastrointestinal tract. Its action in the central nervous system has not been well characterized.
Wu, KJ;Chen, YH;Bae, EK;Song, Y;Min, W;Yu, SJ
core   +1 more source

Combining 2′-fucosyllactose and galacto-oligosaccharides exerts anti-inflammatory effects and promotes gut health

open access: yes
: This study investigated the potential of 2′-fucosyllactose (2′-FL) and galacto-oligosaccharides (GOS) combinations as a novel and cost-effective substitute for human milk oligosaccharides (HMO) in promoting gut health and reducing inflammation.
Jung-il Kwon   +7 more
core   +1 more source

Production of a human milk oligosaccharide 2′-fucosyllactose by metabolically engineered Saccharomyces cerevisiae

open access: yes, 2018
Background 2′-Fucosyllactose (2-FL), one of the most abundant oligosaccharides in human milk, has potential applications in foods due to its health benefits such as the selective promotion of bifidobacterial growth and the inhibition of pathogenic ...
Suryang Kwak   +5 more
core   +1 more source

Home - About - Disclaimer - Privacy